Lv33
290 积分 2024-07-01 加入
Efgartigimod for generalized myasthenia gravis with or without anti-acetylcholine receptor antibodies: a worldwide and Japanese perspective
15天前
已完结
Real-World experience with efgartigimod in patients with myasthenia gravis
16天前
已完结
Clinical efficacy and safety of efgartigimod for treatment of myasthenia gravis
2个月前
已完结
Single institution experience with efgartigimod in patients with myasthenia gravis: Patient selection, dosing schedules, treatment response, and adverse events
2个月前
已完结
皖公网安备34019202002308
